PRODUCT CENTER
Biochemical Raw material
- α-L-fucosidase
- 3 α-Hydroxysteroid Dehydrogenase
- α-Glucosidase
- D-3-Hydroxybutyrate Dehydrogenase
- Lactic Oxidase
- D-lactate Dehydrogenase
- Sialidase
- Purine Nucleoside Phosphorylase
- Uricase- version
- Fructosyl-peptide Oxidase
- Glycerol Kinase
- Sarcosine Oxidase
- Creatinine Amidohydrolase
- Peptide N-glycosidase F
- Cholesterol Oxidase
- Cholesterol Esterase
- Cystathionine-β-synthase
- Cystathionase β-lyase
- Malate Dehydrogenase
- Glucose Dehydrogenase (FAD)
- Ketoamine Oxidase
- Sphingomyelinase
- Diaphorase
- β-HBDH assay kit (enzymatic method)
- FluoS Loop-mediated Amplification Kit
- Low-density lipoprotein cholesterol (LDL-C) linear high
- Homocysteine (HCY)
- Total bile acid (TBA) assay kit (enzyme cycling method)
- Free fatty acid (NEFA)
- Albumin (ALB)
- Glycated Albumin(GA)
- Glycated hemoglobin (HbA1c)
- Adenosine Deaminase (ADA)
- Creatinine (Cre) Assay kit
- Creatine Kinase-MM Isoenzyme (CK-MM) Antibody
- Serum amyloid A (SAA)
- Hemoglobin (Hb)
- Low-density lipoprotein cholesterol (LDL-C) linear high
mRNA vaccine
mRNA synthesis raw material
- BsaI
- BspQI
- mRNA Cap-2′-O-Methyltransferase
- T7 RNA Polymerase
- DNase I
- RNase Inhibitor(Recombinant)
- Pyrophosphatase Inorganic(yeast)
- Vaccinia Capping Enzyme
- Alkaline Phosphatase
- mRNA (raw)
- N1-Me-Pseudo UTP sodium solution
- Poly(A) Polymerase
- S-adenosylmethionine (SAM)
- Pseudo UTP Sodiumsolution
- UTP Sodiumsolution
- CTP sodium solution
- ATP sodium solution
- GTP sodium solution
- High Yield RNA Synthesis Kit(≥2000nt)
- High Yield RNA Synthesis Kit(＜2000nt)
Biopharmaceutical raw material and kit
- DNase assay Kit (Fluorescence)
- RNase assay Kit (Fluorescence)
- UltraNuclease
- Ultra Nuclease Assay Kit (ELISA)
- Recombinant Trypsin
- Recombinant Trypsin Assay Kit (ELISA)
Biopharma
Biopharmaceutical raw materials are mainly natural biological materials, and with the development of biotechnology, purposefully artificially prepared biological raw materials have become the main source of current biopharmaceutical raw materials. It is widely used in the research and development and production process of mRNA vaccines, inactivated vaccines, blood products, antibody drugs, recombinant therapeutic proteins, gene therapy and other biological products. Hzymes Biotech is based on unique technical advantages. R&D and production of GMP-grade all-round nucleases and recombinant trypsins, and provide one-stop solutions for mRNA vaccine and drug development/production.
mRNA vaccine
Based on their unique mechanism of action, mRNA drugs have great potential for application in the treatment of infectious diseases, cancer and rare diseases. Hzymes Biotech can stably supply GMP-grade enzyme raw materials, substrates and detection kits required for mRNA vaccines. At the same time, Hzymes Biotech undertakes commissioned development (CRO) services to provide professional solutions from templates, transcription to modification.
UltraNuclease
Hzymes Botech provides GMP-level all-round nucleases derived from Serratia visceralis, genetically engineered to degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, cyclic, double-helix, natural and denatured nucleic acids, digest them into 3-5 base length 5′-monophosphate oligonucleotide residue fragments, which can be applied to lentiviral purification, vaccine production, drug purification, gene therapy and other fields.
Recombinant Trypsin
Hzymes Biotech recombinant trypsin, can specifically cleave lysine and arginine C-terminal peptide bonds, widely used in tissue and monolayer cell dissociation. Compared with trypsin extracted from pigs and cattle pancreas, recombinant trypsin has higher biosecurity and can replace the traditional extraction of pancreatin in the biopharmaceutical industry where there are strict restrictions on animal-derived materials such as vaccines, stem cells, immune cell therapy, and insulin production.